Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Prot #CC-220-SLE-001: A PILOT, PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, STUDY TO EVALUATE EFFICACY, SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND PHARMACOGENETICS OF CC-220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Laumann, Anne E
(PD/PI)
Dermatology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/7/15
→
4/7/19
Funding
PPD Development
(Prot #CC-220-SLE-001)
Celgene Corporation
(Prot #CC-220-SLE-001)
View all
View less